Transdermal Compound Relief | 1:1 | 200mg
7 left in stock – order soon!
THC is the primary cannabinoid responsible for the psychoactive effects associated with cannabis. The amount of THC in a product can vary widely based on the method of consumption and the strain at the source of that product. The high that is produced is often enhanced by the “entourage effect” which is a combination of multiple cannabinoids in conjunction with various terpenes and individual body chemistry.
CBD is the second most prevalent cannabinoid and is primarily produced by hemp plants and at lower amounts in cannabis. CBD has soared in popularity due to its non-psychoactive effects.
Mary's Medicinals Relief 1:1 Transdermal Compound (200mg total cannabinoids) is a spot-specific, fast-absorbing balm. It blends equal parts THC and CBD with a cooling menthol feel. Unlike standard topicals, it uses special carrier agents to penetrate deeper past the skin barrier for targeted, long-lasting comfort.
Best known as the developer and exclusive distributor of the award-winning Transdermal Cannabis Patch, Mary’s is transforming how people view and utilize cannabis; developing products that maximize the benefits of cannabinoids, terpenes and other plant nutrients.
In addition to being the first to deliver transdermal cannabis products, Mary’s was first-to-market the useful benefits of THCa and CBN, discovered harvesting techniques for the isolation of CBC, and continues to develop new cutting-edge approaches for isolating, manufacturing and marketing medicinal cannabis.
From our founder and partners to our scientists and production associates, our passion is paramount in everything we do. We firmly believe in the healing benefits of plant-based medicine and in particular, cannabis – both from our own experiences and the incredible results we witness in patients.